天然产物 天然产物苯丙素类 Phenylpropanoids
Licarin B (Synonyms: (-)-Licarin B) 纯度: 99.71%
Licarin B 可来源于 Myristica fragrans 的种子,是 NO 生成的抑制剂,可通过激活 IRS-1/PI3K/AKT 通路中的 PPARγ 和GLUT4 改善胰岛素敏感性。
Licarin B Chemical Structure
CAS No. : 51020-87-2
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
5 mg | ¥480 | In-stock | |
10 mg | ¥750 | In-stock | |
50 mg | 询价 | ||
100 mg | 询价 |
* Please select Quantity before adding items.
Licarin B 相关产品
•相关化合物库:
- Natural Product Library Plus
- Bioactive Compound Library Plus
- Cell Cycle/DNA Damage Compound Library
- Membrane Transporter/Ion Channel Compound Library
- Natural Product Library
- Anti-Aging Compound Library
- Medicine Food Homology Compound Library
- Glycolysis Compound Library
- Glutamine Metabolism Compound Library
- Traditional Chinese Medicine Monomer Library
- Anti-Cancer Metabolism Compound Library
- Anti-Obesity Compound Library
- Transcription Factor Targeted Library
- Lipid Metabolism Compound Library
- Glucose Metabolism Compound Library
生物活性 |
Licarin B, a nitric oxide production inhibitor extracted from the component of the seeds of Myristica fragrans, improves insulin sensitivity via PPARγ and activation of GLUT4 in the IRS-1/PI3K/AKT pathway[1][2][3]. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target |
|
||||||||||||||||
体外研究 (In Vitro) |
Licarin B (5 μM, 10 μM, 15 μM. 8 days) moderately increases TG accumulation during adipogenic differentiation and showed partial PPARg agonist activity in 3T3-L1 preadipocytes[2]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability Assay[1]
Cell Viability Assay[1]
|
||||||||||||||||
分子量 |
324.37 |
||||||||||||||||
Formula |
C20H20O4 |
||||||||||||||||
CAS 号 |
51020-87-2 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 100 mg/mL (308.29 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|